SCOPE School London 2016

The theme of this SCOPE School event was Advances in Diabetes & Obesity Management: Clinical Pathways. 

Our international panel of renowned experts answered the questions ‘How do we adapt diet approaches for patients with obesity with or without diabetes?’, ‘What are the differences between bariatric surgery and diabetes surgery?’, ‘What strategies have commercial companies used to incorporate meal replacement strategies within a wider program that also includes exercise?’ and many further interesting topics. The two days included case studies from participants and group discussions.

SCOPE School is an interactive learning experience which includes practical sessions, case studies, lectures and panel discussions. 

These events are targeted at professionals working in clinical practice, including: nurses, nutritionists, physiotherapists and anybody who works directly with obese patients as well as students training in the area of obesity. 

The event took place 14th-15th June 2016 in London, UK.

/ Programme

Download the Conference Programme

/ Speaker Slides

How to approach management of the patient with obesity and prediabetes? - Nick Finer, UCL, UK

How can primary care contribute? Integrating care and developing patient pathways - Carly Hughes, NHS North Norfolk, UK

Are we treating a patient with obesity complicated by diabetes or a patient with diabetes complicated by obesity? - Abd Tahrani, University of Birmingham, UK

How do we adapt diet approaches for patients with obesity with or without diabetes? - Therese Coleman, Medfit, Ireland

Using non-commercial meal replacement strategies for the treatment of obesity and how to adapt them for patients with obesity and diabetes - Therese Coleman & Nick Finer

What have we learnt from clinical trials of patients with obesity where the intervention aimed to improve their glycaemic control? - Alex Miras, Imperial College London, UK

The purpose, challenges, environment and processes required to have a positive impact with exercise in both the obese and type 2 diabetic populations - John Murphy, Medfit, Ireland

Managing the dysregulation of the metabolic milieu in patients with obesity with or without diabetes. What are risk benefit ratio of treatments? - Francis Finucane, National University of Ireland, Ireland

Understanding the clinical trials of drugs aimed at patients with diabetes and obesity - Francis Finucane, National University of Ireland, Ireland

What are the differences between bariatric surgery and diabetes surgery? - Carel le Roux, University College Dublin

 

For enquiries please contact scopeschool@worldobesity.org